B. Crichi

发表

Patient education program at the forefront of cancer-associated thrombosis care.

D. Farge, C. Frère, A. Ndour, 2021, Journal de medecine vasculaire.

Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).

A. Carpentier, J. Gris, E. Messas, 2020, Journal de medecine vasculaire.

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?

C. Frère, J. Spano, N. Janus, 2020, Cancers.

Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

F. Pomero, L. Mazzolai, P. Prandoni, 2021, Journal of the American Heart Association.

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2022, Pilot and Feasibility Studies.

Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study.

C. Frère, N. Janus, Z. Marjanovic, 2022, Journal de medecine vasculaire.

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

J. Douketis, W. Ageno, A. Khorana, 2022, The Lancet Oncology.

The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis

D. Farge, C. Frère, J. Connault, 2022, Journal of clinical medicine.

First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

L. Mazzolai, P. Prandoni, E. Grandone, 2020 .

Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer.

D. Farge, L. Deville, Z. Marjanovic, 2020, Journal de medecine vasculaire.

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

P. Prandoni, L. Bertoletti, P. Verhamme, 2021, Internal and Emergency Medicine.

Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2022, Trials.

Hemostasis testing in patients with liver dysfunction: Advantages and caveats

B. Crichi, Corinne Frère, M. Lejeune, 2021, World Journal of Gastroenterology.

The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, Trials.

How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units

D. Farge, C. Frère, P. Bonnin, 2020, JMV-Journal de Médecine Vasculaire.

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis

C. Frère, J. Connors, D. Bonnefont-Rousselot, 2020, JMV-Journal de Médecine Vasculaire.

Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis

C. Font, C. Frère, N. Janus, 2021, Supportive Care in Cancer.

How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital.

D. Farge, C. Montlahuc, S. Villiers, 2020, Journal de medecine vasculaire.

Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study.

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, The Lancet. Rheumatology.

Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study

D. Farge, C. Montlahuc, S. Villiers, 2021, Journal of Thrombosis and Thrombolysis.

Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

D. Farge, L. Buscail, C. Frère, 2020, Cancers.

A review of latest clinical practice guidelines for the management of cancer-associated thrombosis.

D. Farge, Z. Marjanovic, B. Crichi, 2022, Baillière's Best Practice & Research: Clinical Haematology.

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, Trials.

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2023, EClinicalMedicine.

[Venous thromboembolism and breast cancer].

D. Farge, E. Moati, B. Crichi, 2023, Bulletin du cancer.

A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team members

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2023, Disability and rehabilitation.

Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus disease (COVID-19) vaccination.

M. Para, G. Soulat, B. Crichi, 2024, Current research in translational medicine.